Virtu Financial LLC Invests $854,000 in Teladoc Health, Inc. $TDOC

Virtu Financial LLC purchased a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 121,984 shares of the health services provider’s stock, valued at approximately $854,000.

A number of other institutional investors also recently modified their holdings of the company. Corient Private Wealth LLC grew its stake in Teladoc Health by 236.6% in the 4th quarter. Corient Private Wealth LLC now owns 37,692 shares of the health services provider’s stock valued at $264,000 after buying an additional 26,494 shares during the last quarter. Mackenzie Financial Corp raised its holdings in Teladoc Health by 38.6% in the 4th quarter. Mackenzie Financial Corp now owns 165,550 shares of the health services provider’s stock worth $1,157,000 after acquiring an additional 46,090 shares during the period. Empowered Funds LLC lifted its position in Teladoc Health by 1.9% during the 4th quarter. Empowered Funds LLC now owns 742,305 shares of the health services provider’s stock worth $5,196,000 after acquiring an additional 14,029 shares during the last quarter. Voloridge Investment Management LLC lifted its position in Teladoc Health by 42.8% during the 4th quarter. Voloridge Investment Management LLC now owns 997,427 shares of the health services provider’s stock worth $6,982,000 after acquiring an additional 299,086 shares during the last quarter. Finally, Polymer Capital Management US LLC boosted its holdings in Teladoc Health by 32.0% during the fourth quarter. Polymer Capital Management US LLC now owns 22,443 shares of the health services provider’s stock valued at $157,000 after acquiring an additional 5,443 shares during the period. Institutional investors own 76.82% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Charles Divita III sold 19,132 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $145,977.16. Following the completion of the sale, the chief executive officer owned 389,894 shares of the company’s stock, valued at $2,974,891.22. This trade represents a 4.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Adam C. Vandervoort sold 7,906 shares of Teladoc Health stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $60,322.78. Following the completion of the sale, the insider directly owned 110,261 shares of the company’s stock, valued at $841,291.43. This trade represents a 6.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 39,870 shares of company stock valued at $302,507. Company insiders own 0.70% of the company’s stock.

Teladoc Health Trading Down 0.1%

Shares of TDOC stock opened at $8.06 on Monday. The firm has a fifty day moving average of $6.63 and a 200-day moving average of $6.23. The stock has a market cap of $1.46 billion, a price-to-earnings ratio of -8.31 and a beta of 2.14. Teladoc Health, Inc. has a 52-week low of $4.40 and a 52-week high of $9.77. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.72 and a current ratio of 2.80.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The company had revenue of $613.85 million for the quarter, compared to analyst estimates of $611.04 million. During the same period in the previous year, the firm posted ($0.53) earnings per share. The firm’s revenue for the quarter was down 2.5% compared to the same quarter last year. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. On average, equities research analysts forecast that Teladoc Health, Inc. will post -0.92 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have issued reports on TDOC. Deutsche Bank Aktiengesellschaft raised Teladoc Health from a “hold” rating to a “buy” rating and set a $11.00 target price on the stock in a report on Tuesday, March 10th. BMO Capital Markets cut their price target on Teladoc Health from $8.00 to $5.00 and set a “market perform” rating for the company in a report on Thursday, February 26th. Stifel Nicolaus reduced their price objective on Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a research report on Thursday, February 26th. TD Cowen lowered their price objective on shares of Teladoc Health from $8.00 to $6.00 and set a “hold” rating on the stock in a research note on Thursday, February 26th. Finally, Bank of America raised shares of Teladoc Health from a “neutral” rating to a “buy” rating and set a $7.00 target price on the stock in a research report on Thursday, February 26th. Five investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Teladoc Health currently has an average rating of “Hold” and an average target price of $7.43.

Teladoc Health Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.